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are separated by intervening non-coding sequences
(introns). Some small human genes span 2000 or 3000 base
pairs (bp). Genes encoding large polypeptides can have
more than 100 exons and can be more than 1 million bp
long. Intergenic regions do not code for protein, but indi-
rectly can influence gene expression by affecting the forma-
tion of higher order chromatin structures. These include
open chromatin (euchromatin), which is a minimal require-
ment for expression of nearby genes, or condensed chro-
matin (heterochromatin), which is transcriptionally silent.
Gene regulation. Each gene has a promoter, which
is the recognition site used by the RNA polymerase
enzyme complex as it begins to interpret the genetic code
that it encounters along the chromosome. Regulatory
proteins bind to promoter regions and guide the RNA
polymerase complex to the start site; most stimulate initi-
ation, but some suppress transcription. Gene promoters,
composed of several short (5-10 bp) sequences, are found
near genes expressed in a certain cell type or by a certain
stimulus and are often identical. These common regula-
tory sequences give genes encoding unrelated proteins the
capacity for co-expression. Some regulatory sequences can
act as promoters for one gene, enhancers for another, and
suppressors for other genes.
There are an estimated 10,000 to 100,000 genes coding
for proteins along the 22 human autosomes and the X and
Y sex chromosomes. Each cell type in an individual human
has the same chromosome content, except for the rearrange-
ments and deletions that occur naturally in the course of 
B lymphocyte immunoglobulin gene and T lymphocyte
antigen receptor gene expression. The mRNAs produced by
transcription of the genes in a particular cell type are unique
for specific physiological or experimental conditions. Some
proteins are maintained at constant concentrations in the cell
in all circumstances and are encoded by the “housekeeping”
genes (eg, actin, reduced nicotinamide adenine dinu-
cleotide). Exceptions in specific cell types occur, and more
sensitive or specific tests of gene function are necessary to
reveal subtle regulatory differences. All cell types undergo
changes in gene expression during their normal cellular
functions. The expression of most proteins is regulated over
tissue development, over the course of the cell cycle in nor-
mal growth, and with particular conditions, in response to
acute stimuli for cellular activation.
The flux of intermediate forms of chromatin and spe-
cialized organelles within the nucleus likely represent addi-
Molecular biology, the study of the mechanisms of
transmission of genetic information, is integral to the
understanding of vascular disease processes. Implicated in
the initiation and progression of cardiovascular disease are
single-gene defects and multiple-gene products interact-
ing with environmental factors. Basic concepts and defini-
tions for studying the mechanism of gene expression and
an overview of commonly applied laboratory techniques
are reviewed.
TRANSCRIPTION AND TRANSLATION OF THE
GENETIC CODE
Deoxyribonucleic acid (DNA), a long polymer of
linked nucleotides with deoxyribose as their sugar and a
hydrogen-bonding base pair (guanine, cytosine, adenine,
or thymine), can form double-stranded or helical struc-
tures and is the fundamental substance that forms genes.
In vivo, DNA is complexed to DNA-binding proteins to
form a three-dimensional supercoiled state. This con-
densed DNA structure is commonly known as chromatin.
Three major processes involve the transmission of genetic
information from DNA (Fig 1): (1) replication of the
DNA molecule by a template mechanism (nucleus); (2)
transcription, the process of ribonucleic acid (RNA) syn-
thesis by DNA (nucleus); and (3) translation of messenger
RNA (mRNA), an RNA molecule transcribed from the
DNA of a particular gene, which results in protein synthe-
sis (cytoplasm). These synthesized proteins are integral to
cell structure and function.
A gene is a segment of DNA involved in production of
an RNA chain and sometimes a polypeptide. Genes that
encode proteins comprise several basic elements. mRNA-
encoding sequences (exons) are usually discontinuous and
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tional mechanistic components operating to regulate gene
expression. These sites of interaction of multi-protein com-
plexes with chromatin carry out DNA replication, repair,
and transcription; sites of interaction of other multi-protein
complexes with newly synthesized RNA carry out capping,
polyadenylation, splicing, and transport.
Gene expression. Gene expression involves the transfer of
coding information from DNA to mRNA (transcription;
Fig 1B) and the subsequent decoding of the gene
sequence resulting in the production of protein (transla-
tion; Fig 1C). Re-introducing the molecular construct
into cells allows one to follow the production of the
reporter mRNA, reporter protein, or both and to deter-
mine whether the control sequence is sufficient to induce
expression. Conversely, in the preparation of a series of
constructs (eg, 5'-deletion mutants) some of these artifi-
cial DNA sequences cannot promote the expression of an
adjacent protein-encoding sequence when critical stimula-
tory regions are removed. The sequence of a promoter is
often initially discernible because of its similarity to pro-
moters from other previously characterized genes. The
characteristics of a gene promoter can vary depending on
the assay used: a promoter-reporter construct may be
expressed at one level in vitro with cell extracts, at a dif-
ferent level when transferred into living cells, or still dif-
ferently when engineered into the genome of a line of
transgenic animals. Manipulation of the cell cycle has been
used as a means of better understanding arterial disease
processes.
Cell cycle. Most cells are in the G0 phase and are
non-cycling. For a cell to replicate, it enters the cell cycle.
The four basic phases recognized in the cell cycle (Fig 2)
are: (1) the Gap1 (G1) phase, involving most protein
biosynthesis; (2) the Synthesis (S) phase, entailing most
DNA synthesis and some S-phase–specific protein synthe-
sis; (3) the Gap2 (G2) phase, involving some protein syn-
thesis in preparation for mitosis; and (4) the Mitosis (M)
phase, in which there is shut-down of protein and DNA
synthesis and chromosome condensation for mitosis. The
phases of the cell growth cycle except mitosis are called
interphase, and it is during interphase that gene expression
is observed. There are functionally significant links
between the transcription-translation systems that yield
proteins and the replication systems that yield DNA.
Manipulation of the cell cycle has been used as a means of
better understanding arterial disease processes.
Apoptosis. Apoptosis, defined as “programmed cell
death,” is recognized in both normal adaptive responses
(tissue homeostasis) and pathologic states in which a cell
actively participates in its own cell death. The morpholog-
ical features associated with apoptosis are loss of cell mem-
brane asymmetry and attachment, condensation of
cytoplasm and nucleus, and internucleosomal cleavage of
DNA. The dying cells then become fragmented into apo-
ptotic bodies, which are eliminated by phagocytic cells
without eliciting significant inflammatory damage to sur-
rounding cells. Both morphological features and the lack
of an inflammatory response distinguish apoptosis from
necrosis. Inappropriate regulation of apoptosis has been
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Fig 1. Transcription and translation of the genetic code. The three major processes involved in the transmission of genetic information are:
A, DNA replication, which involves the synthesis of a complementary strand of an original DNA template; B, DNA transcription, in which
a complementary mRNA strand is synthesized from an original DNA template; and C, translation of mRNA, resulting in protein synthe-
sis. Each process is represented in this figure, with the commonly used molecular biology techniques applied to study these processes.
A B C
suggested in certain pathological states such as ischemia,
stroke, atherosclerosis, and intimal hyperplasia.
METHODOLOGY AND EXPERIMENTAL
DESIGN
The methodology currently available can precisely
detect similarities and differences between biomolecules
from changes of a single base to rearrangements of an
entire gene region. The resulting differences in the pro-
teins encoded can be predicted by means of comparison to
known structural motifs and can also be observed in the
test tube or experimental animal, with actual production
of natural and mutant recombinant molecules. The ability
to isolate genes and disassemble and reassemble them and
to produce replenishable supplies of the DNA, encoded
RNA, and recombinant protein from each of these con-
structions is largely caused by the commercial availability
of hundreds of purified and well-characterized enzymes.
With these powerful methods of handling DNA, naturally
occurring mutants are no longer required to correlate
structure and function.
The study of the intact cardiovascular system in animal
models is a useful means of studying human disease
processes at the molecular level. Animal studies are suit-
able for studying the development of pathological condi-
tions at the molecular level and are needed to test
procedures involving gene therapy that can then be
extended to human clinical trials. Whole animal experi-
ments also include the production of transgenic rodents or
other animals, with an added gene construct, or the prepa-
ration of knockout mice, with a gene deleted by homolo-
gous recombination with a deletion construct.
In situ analysis of biomolecules provides positional
information about the subcellular, cellular, or tissue level
of activity. Histological sections can be analyzed for gene
localization with chromosomal in situ hybridization, for
mRNA localization to cell types in a tissue with in situ
hybridization, and for antigen localization with immuno-
cytochemistry. The orientation of polarized cells (eg, vas-
cular endothelial cells) and their different cell membrane
domains in intact tissues can provide experimental meth-
ods for manipulating molecular processes at one cell sur-
face, for gene targeting to a cell facing the lumen, and for
the preparation of specific cellular membranes, organelles,
and molecules that would be randomly sampled in a total
tissue preparation.
Continuously growing cell lines (human or animal) as
models for the biology of normal cells are derived from a
clone of cells recovered after the transforming events of
tumorigenesis and subsequently selected biologically for
survival. Continuously growing cell lines are convenient,
reliable, and produce more easily reproducible results than
studies with preparations of cells from whole organs. A
basic disadvantage of using cell lines is the difference in
control of growth and differentiation states seen in trans-
formed cells. Therefore, in most in vitro studies, early pas-
sage vascular cells are used so that findings are more
applicable to in vivo processes.
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Cell signaling pathways in human cells play critical
roles in cell behavior and subsequent normal, adaptive,
and pathologic responses. Signal transduction pathways
extend into the cell from the extracellular environment
through one or more domains of the cell membrane and
the cytoplasm to the nucleus, where responses are carried
out by gene expression. Specific membrane receptors are
linked to signaling systems at the inside face of the cell
membrane, and consist of glutamyl transpeptidase-binding
proteins, second messenger generating enzymes, protein
kinases, nucleotide, lipid, and cation substances, and their
associated regulatory proteins. Responses potentially
involve immediate cell activation, proliferation, differentia-
tion, and/or migratory processes. The particular subcellu-
lar localizations of molecular events in the pathophysiology
of the cardiovascular system are important for designing
improved diagnostic and potentially therapeutic interven-
tions involving the smooth muscle cells, endothelial cells,
macrophages, T lymphocytes, and platelets. The modula-
tion of gene expression in these cell types is intimately
involved with the normal and pathological responses to
external events, and the control points regulating gene
expression provide numerous specific targets for novel
diagnostic and therapeutic approaches to cardiovascular
disease.
DNA ANALYSIS AND GENE STRUCTURE
Modeling of the genetic transmission of genetic infor-
mation in living cells and in enzyme-catalyzed reactions
generates molecular products. The desired products are
called signals, and the unwanted materials are called noise.
The experimental use of the enzymes’ DNA-dependent
DNA polymerases (DNA replication), RNA-dependent
DNA polymerases (reverse transcription), and DNA-
dependent RNA polymerases (gene transcription) pro-
vides specific information and the molecular production
by various cellular and viral gene machines. Methods of
DNA analysis are listed in Fig 1A.
The types of DNA molecules used in molecular biol-
ogy can be conveniently categorized by means of size and
Fig 2. The cell cycle. The four basic phases of the eukaryotic cell
cycle are shown. The G1 phase involves most protein biosynthe-
sis. The S-phase entails most of the cell’s DNA synthesis and some
additional protein synthesis. The G2 phase is characterized by the
protein synthesis necessary for mitosis. In the M phase, the chro-
mosomes condense and cell replication (mitosis) is initiated.
are categorized as synthetic oligodeoxynucleotides or oli-
gos (single-stranded linear sequence of nucleotides), plas-
mids (an extrachromosomal autonomously replicating
circular DNA segment), bacteriophage DNA, single-
stranded phage and phagemid DNA, linear fragments of
DNA constructs, genomic DNA, linear fragments of
genomic DNA, chromatin, and chromosomes. Each of
these molecular forms of DNA can be used as substrates or
analytical probes for specialized techniques. Selected tech-
niques will be described in more detail.
Southern blot analysis. Southern blotting was
developed by E.M. Southern as a means of providing pre-
liminary information on gene structure. This technique
involves transfer of denatured DNA from agarose gel to a
nitrocellulose or nylon filter, where it can be annealed with
a radio-labeled complementary nucleic acid.
Vectors for cloning. A vector is a self-replicating
DNA molecule that transfers a DNA segment between
host cells and provides for self-replication, with or without
the expression of the foreign DNA as RNA and protein.
Subsequently, many specialized vectors that can perform
intricate molecular manipulations with DNA, RNA, or
protein have been designed. These vector sequences
encode a few important functions that give the cell con-
taining the foreign DNA certain reproductive advantages.
Complementary DNA cloning. Complementary
DNA (cDNA) is a single-stranded DNA copy of an
mRNA made with the use of the enzyme reverse tran-
scriptase; cDNA contains only the coding sequences of a
gene. A cDNA library consists of a collection of DNA
molecules comprising the chosen vector sequence and any
one of the thousands or millions of cDNAs representing
the genes expressed in the cells used for the original RNA
source. The vector, also known as a vehicle, can be a plas-
mid or a bacteriophage. All cDNA vectors include a
sequence that functions as a bacterial origin of DNA repli-
cation, and this allows the production in bacteria of a large
number of copies of the entire plasmid construct, inde-
pendent of bacterial cell growth.
Mammalian gene promoters and enhancers. Well-
characterized promoters and enhancers of gene expression
can be used in the design of an effective mammalian
expression vector. In some instances, a promoter isolated
from a genomic clone of a mammalian gene is useful for
cloning genes functionally related to the promoter chosen.
The functional characteristics of a particular region of a
gene are commonly determined by their stimulation of
gene expression in cells or in cell extracts, and the result-
ing RNA or protein gene products are detected by means
of a specific assay. The structural characteristics of a gene
promoter or enhancer can often be observed in experi-
mental systems by the binding of particular proteins.
Polymerase chain reaction. Polymerase chain reac-
tion (PCR) is an in vitro method for the enzymatic syn-
thesis of specific DNA sequences by repetitive cycles,
resulting in an exponential increase in product. This
method uses two synthetic oligonucleotide primers flank-
ing the region of interest in the target DNA and DNA
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Fig 3. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. DNA
strand breaks with exposed carboxy (-OH) termini are labeled, conjugated, and studied to determine in
vitro pre-programmed cell death or apoptosis.
polymerase to amplify these sequences. At the completion
of each cycle of this repetitive production of the DNA
located between the primer-binding sites, the original
DNA template and the DNA product separate, becoming
substrates for each subsequent reaction. PCR can be
applied to the routine preparation of DNA fragments of
previously sequenced genes, to the detection and quantifi-
cation of mutant alleles or variant alleles of a known gene,
and to clinical assays for the detection of viral sequences,
oncogene mutations, and other disease-associated or nor-
mal alleles of any gene that has been previously cloned and
sequenced.
DNA sequencing. DNA sequencing is based on
sequence information obtained by means of generation of
DNA fragments of different lengths, which start at a fixed
point and terminate at specific nucleotides. The DNA
fragments are separated precisely by size with elec-
trophoresis on a denaturing polyacrylamide gel.
Fragmentation can be produced with chemical cleavage or
enzymatic copying of single-stranded DNA. The results
from the gel are read by detecting bands from the bottom
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of the gel in succession from the alternate lanes marked for
the nucleotides A, C, G, or T and recording the sequence
of these signals in a linear array, the DNA sequence.
In vitro mutagenesis of cloned DNA. The routine
modifications of a single nucleotide, a short region of
sequence, or kilobases of DNA are feasible by means of the
approach of in vitro mutagenesis with a cloned gene as a
template in a plasmid vector and a specifically designed
synthetic oligodeoxynucleotide as the mutagenic primer.
The oligonucleotide is designed to include perfect
matches to sequences flanking the modified site. The
products are the original sequence plus a mutated
sequence. Several sophisticated variations provide for
direct selection of mutated plasmid sequences. Essentially
any variation of the original cloned gene can be readily
prepared in large quantities. These types of preparations
are critical for the precise mapping of DNA functions and
are often required in the construction of multi-component
DNA constructs for special uses.
Terminal deoxynucleotidyl transferase-mediated
dUTP nick end labeling assay. The terminal deoxynu-
Fig 4. Western immunoblot analysis. Cell lysates are subjected to electrophoresis, transferred to a nitro-
cellulose membrane, incubated with protein-specific primary and marker-labeled (conjugated) secondary
antibodies, and subsequently detected by means of chemiluminescence and x-ray film development.
Fig 5. Enzyme-linked immunosorbent assay (ELISA). Immobilized antigens are incubated with protein-
specific primary antibodies and marker-labeled (conjugated) secondary antibodies. Protein complexes are
then quantified by means of colorimetric assay.
cleotidyl transferase-mediated dUTP nick end labeling
(TUNEL) assay is used as a means of detecting apoptosis
by preferentially labeling DNA strand breaks generated
during apoptosis and can distinguish these cells from cells
undergoing necrosis (Fig 3). DNA strand breaks with free
3'-OH termini are labeled in an enzymatic reaction. Then
terminal deoxynucleotidyl transferase, which catalyzes
polymeration of nucleotides to free 3’-OH DNA ends, is
used to label DNA strand breaks. Incorporated fluorescein
is detected by means of antifluorescein antibody fragments
and conjugated with alkaline phosphatase. The apoptotic
cells are stained and can be viewed with a light micro-
scope.
RNA ANALYSIS AND GENE EXPRESSION
mRNA quantity, size, and cellular localization demon-
strate the varying status of gene expression. Transcription
initiation, in which most gene regulation apparently
occurs, is the most difficult aspect of mRNA biosynthesis
to monitor directly. The resulting steady-state levels of
mRNA and polypeptide encoded by a gene are more read-
ily detectable, and most analyses of gene expression deal
with differences in steady-state levels of gene products in
varying physiological or pharmacological conditions.
Selected techniques will be discussed, and a more com-
plete list is given in Fig 1B.
In situ hybridization. In situ hybridization is used as
a means of localizing, within intact chromosomes, eukary-
otic cells, or bacterial cells, nucleic acid segments comple-
mentary to specific labeled probes. To localize specific
DNA sequences, specimens are treated so as to denature
DNAs and to remove adhering RNAs and proteins. The
DNA segments of interest are then detected by means of
hybridization with labeled nucleic acid probes. The distri-
bution of specific RNAs within intact cells or chromo-
somes can be localized by means of hybridization of
sectioned specimens with an appropriate RNA or DNA
probe.
Northern blot analysis. Northern blot analysis is
used as a means of examining size and abundance of
mRNA. This technique involves the transfer of RNA from
agarose gel to a nitrocellulose or nylon filter on which it
can be hybridized to a complementary nucleic acid. It is
generally used as a means of examining size and abun-
dance of mRNA.
TRANSLATION
Historically, the in vitro kinase assay was the primary
method of quantifying phosphorylated (activated) pro-
teins. Subsequently, immunoprecipitation was used for the
isolation of specific proteins in solution, and then Western
blot analysis was performed as a means of isolating the
phosphorylated protein from the total protein. More com-
monly, phosphospecific antibodies are available and used
as a means of directly detecting activated protein.
Common methods used as a means of analyzing the prod-
ucts of translation are listed in Fig 1C. Selected techniques
are described.
Western blot analysis. Western blotting is used as a
means of immunodetecting specific proteins (Fig 4). It is
a procedure for the transfer of protein products from an
acrylamide gel to a nitrocellulose filter that is subsequently
incubated with protein-specific antibodies. The protein-
bound antibody is then detected with a secondary anti-
body. Signals are generated by means of an enzymatic
reaction and detected by using an x-ray film.
Enzyme-linked immunosorbent assay. The enzyme-
linked immunosorbent assay technique is used as a means
of quantifying specific protein antigens in a solution (Fig
5). Although there are different protocols, generally the
antigen is linked to an antibody-enzyme conjugate. The
unbound conjugates are removed, and a chromogenic or
fluorogenic substrate is added. As the substrate is
hydrolyzed by bound enzyme conjugate, a colored or flu-
orescent product proportional to the amount of protein is
generated and quantified with a microplate reader.
CONCLUSION
The technology of molecular biology has changed the
way we study vascular disease. Identifying the mechanisms
responsible for and the molecules involved in these
processes should result in more accurate diagnostic testing
and may facilitate the development of gene and cell therapy.
We thank Beresford Grant for assisting with the prepa-
ration of the figures.
REFERENCES
1. Peyman JA, Sumpio BE. Molecular biology and the vascular surgeon.
In: Sidawy AN, Sumpio BE, Depalma RG, editors. The basic science
of vascular disease. 1st ed. Armonk, NY: Futura; 1997. p. 17-68.
2. Gahtan V, Peyman JA, Sumpio BE. Understanding molecular biology.
Semin Vasc Surg 1998;11:125-33.
3. Alberts B, Bray D, Lewis J, et al. Molecular biology of the cell. 3rd ed.
New York: Garland; 1994.
4. Darnell J, Lodish H, Baltimore D. Molecular cell biology. New York:
Scientific American Books; 1990.
5. Berg P, Singer M. Dealing with genes: the language of heredity. Mill
Valley, Calif: University Science Books; 1992.
6. Watson JD, Hopkins NH, Roberts JW, et al. Molecular biology of the
gene. 4th ed. Menlo Park, Calif: Benjamin/Cummings; 1987.
7. Ausubel FM, Brent R, Kingston RE, et al, editors. Current protocols
in molecular biology. New York: John Wiley & Sons; 1987.
8. Xing Y, Johnson CV, Dobner PR, Lawrence JB. Higher level organi-
zation of individual gene transcription and RNA splicing. Science
1993;259:1326-30.
9. Carter KC, Bowman D, Carrington W, et al. A three-dimensional view
of precursor messenger RNA metabolism within the mammalian
nucleus. Science 1993;259:1330-5.
10. Wansink DG, Schul W, van der Kraan I, et al. Fluorescent labeling of
nascent RNA reveals transcription by RNA polymerase II in domains
scattered throughout the nucleus. J Cell Biol 1993;122:283-93.
11. Kriegler M. Gene transfer and expression: a laboratory manual. New
York: Stockton Press; 1990.
12. Russo VEA, Brody S, Cove D, Ottolenghi S, editors. Development:
the molecular genetic approach. Berlin: Springer-Verlag; 1992.
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed
cell-death in situ via specific labeling of nuclear-DNA fragmentation.
J Cell Biol 1993;119:493-501.
Submitted Aug 28, 2001; accepted Aug 30, 2001.
JOURNAL OF VASCULAR SURGERY
568 Gahtan, Olson, and Sumpio March 2002
